In a filing, Medtronic Plc revealed its Officer Salmon Sean acquired Company’s shares for reported $1.6 million on Jun 06 ’25. In the deal valued at $86.81 per share,18,378 shares were bought.
Then, Wall Brett A. sold 12,437 shares, generating $1,119,330 in total proceeds. Upon selling the shares at $90.00, the EVP & Pres Neuroscience now owns 40,979 shares.
Before that, Wall Brett A. bought 12,437 shares. Medtronic Plc shares valued at $1,119,330 were divested by the Officer at a price of $90.00 per share.
Leerink Partners initiated its Medtronic Plc [MDT] rating to an Outperform in a research note published on June 16, 2025; the price target was $110. A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “a Buy”. RBC Capital Mkts also remained covering MDT and has increased its forecast on October 10, 2024 with a “an Outperform” recommendation from previously “Sector perform” rating. Oppenheimer maintained its rating on August 21, 2024. It rated MDT as “a Perform”.
Price Performance Review of MDT
On Monday, Medtronic Plc [NYSE:MDT] saw its stock jump 0.74% to $87.92. Over the last five days, the stock has gained 0.54%. Medtronic Plc shares have risen nearly 10.07% since the year began. Nevertheless, the stocks have risen 6.92% over the past one year. While a 52-week high of $96.25 was reached on 03/10/25, a 52-week low of $75.96 was recorded on 04/09/25.
Levels Of Support And Resistance For MDT Stock
The 24-hour chart illustrates a support level at 87.41, which if violated will result in even more drops to 86.90. On the upside, there is a resistance level at 88.60. A further resistance level may holdings at 89.28.
